INFLAMMATION MARKERS

Understanding systemic inflammation — what hs-CRP and other markers reveal about chronic inflammation, cardiovascular risk, and how they connect to the rest of your panel.

Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · Updated March 2, 2026

THE BOTTOM LINE

• Your body uses inflammation to fight infections and heal injuries — that is normal and healthy.
• The problem is when low-grade inflammation stays elevated chronically, which is linked to heart disease, metabolic dysfunction, and accelerated aging.
• The main marker on your panel is hs-CRP.
• One important caveat: a single hs-CRP reading can be thrown off by recent illness, injury, or a hard workout. If yours is elevated, your provider may want to retest in a few weeks to confirm it reflects your true baseline.

INTRODUCTION

Inflammation is a biological defense mechanism — the immune system’s response to infection, injury, and tissue damage. In its acute form, inflammation is protective: it isolates threats, recruits immune cells, and initiates repair. A cut that turns red and swollen is acute inflammation working as intended.

Chronic low-grade inflammation is a different process entirely. Rather than a targeted, time-limited response, it represents persistent, low-level activation of inflammatory pathways throughout the body. Research over the past two decades has established chronic systemic inflammation as a common thread connecting cardiovascular disease, metabolic dysfunction, type 2 diabetes, and accelerated aging. This has shifted inflammation from a secondary finding to a primary area of clinical interest.

Blood work can measure specific markers of systemic inflammation, providing a window into this otherwise invisible process. The most widely studied and clinically validated is high-sensitivity C-reactive protein (hs-CRP).

CORE BIOMARKER

hs-CRP (High-Sensitivity C-Reactive Protein)

What it is: C-reactive protein (CRP) is a protein produced by the liver in response to inflammatory signals. CRP levels rise rapidly during infection or injury and decline as the trigger resolves.

Standard CRP vs. hs-CRP: The distinction is in the test sensitivity, not the protein. Standard CRP tests detect levels above approximately 3–10 mg/L and are used to monitor acute conditions like infection or autoimmune flares. The high-sensitivity CRP (hs-CRP) assay measures the same protein at much lower concentrations (below 3 mg/L), making it useful for detecting the subtle, low-grade inflammation associated with cardiovascular risk.

Why it matters — cardiovascular risk: Research has established that chronic inflammation plays a causal role in atherosclerosis — not merely a secondary response to plaque buildup, but an active driver of plaque formation, instability, and rupture.

The American Heart Association and CDC established hs-CRP risk categories:

hs-CRP Level	Cardiovascular Risk Category
Below 1.0 mg/L	Lower risk
1.0–3.0 mg/L	Average risk
Above 3.0 mg/L	Higher risk

These categories come from large studies showing that individuals in the highest hs-CRP group had roughly two to three times the cardiovascular event risk compared to those in the lowest group — independent of traditional risk factors like LDL cholesterol.

The clinical case for hs-CRP: A major clinical trial showed that lowering inflammation — even in people whose cholesterol looked fine — reduced heart disease risk by 44%. This is why your provider may pay attention to hs-CRP independently of your cholesterol numbers.

What elevates hs-CRP: Chronic hs-CRP elevation (consistently above 3.0 mg/L) can reflect multiple underlying drivers:

• Excess body fat, especially visceral fat: Fat tissue is metabolically active and produces inflammatory signals. There is a strong, dose-dependent relationship between body fat and hs-CRP levels.
• Insulin resistance: Elevated insulin and glucose promote inflammatory signaling. hs-CRP and insulin resistance are bidirectionally linked — each worsens the other.
• Smoking: Current smokers have significantly elevated hs-CRP, with levels declining after cessation.
• Poor sleep: Short sleep duration and sleep disorders (particularly sleep apnea) are associated with elevated inflammatory markers.
• Chronic infections: Periodontal (gum) disease, for example, has been associated with persistently elevated hs-CRP.
• Sedentary behavior: Physical inactivity is independently associated with higher CRP, while regular exercise reduces hs-CRP over time.

Important caveat — transient elevations: Acute illness, injury, or recent surgery can spike CRP far above the cardiovascular risk range (sometimes above 100 mg/L). Guidelines recommend that if hs-CRP exceeds 10 mg/L, the result likely reflects an acute process rather than your baseline, and retesting should occur two to three weeks later. Two measurements taken at least two weeks apart provide a more reliable baseline.

ADDITIONAL INFLAMMATION MARKERS

Several other markers may appear on inflammation-focused panels:

ESR (Erythrocyte Sedimentation Rate)

Measures how quickly red blood cells settle in a test tube over one hour. Faster settling indicates higher levels of inflammatory proteins. ESR is nonspecific — it rises with infection, autoimmune disease, and aging — but it complements CRP. While CRP rises and falls rapidly, ESR moves more slowly and may better reflect chronic inflammatory states.

Homocysteine

An amino acid linked to cardiovascular risk, though whether it directly causes harm is still debated. Homocysteine levels are influenced by B12, folate, and B6 status — deficiency in any of these raises homocysteine. Supplementation to lower homocysteine has not consistently reduced cardiovascular events in trials, so it is primarily useful as a marker, not a treatment target.

Ferritin (as an Inflammatory Marker)

While ferritin primarily measures iron storage, it is also a protein that rises during inflammation, independent of iron status. An elevated ferritin may reflect iron overload, active inflammation, or both. Providers often evaluate it alongside hs-CRP to distinguish between causes.

HOW INFLAMMATION CONNECTS TO OTHER PANEL RESULTS

One of the most important aspects of inflammation markers is how they contextualize other blood work results. Inflammation does not operate in isolation — it intersects with metabolic, cardiovascular, and hormonal pathways:

Metabolic Panels

Fat tissue — especially belly fat — produces inflammatory signals that make your cells less responsive to insulin. Higher insulin then triggers more inflammation. It becomes a cycle. When hs-CRP is elevated alongside fasting glucose or insulin, it suggests an inflammatory-metabolic pattern rather than isolated findings.

Lipid Panels

Systemic inflammation modifies cholesterol particles in ways standard lipid panels may not capture. Inflammatory states promote the formation of smaller, denser LDL particles — which are more dangerous — and can reduce HDL functionality even when HDL numbers appear normal.

Thyroid and Hormonal Markers

Chronic inflammation can suppress thyroid function and alter hormone-binding proteins. Elevated hs-CRP in the context of borderline thyroid or hormonal results may warrant a more integrated evaluation.

This interconnection is why providers increasingly evaluate inflammation markers as context for the entire panel, not as standalone results. See How Your Markers Connect for a deeper look at these patterns.

WHAT AFFECTS YOUR RESULTS

Understanding what influences hs-CRP helps distinguish meaningful results from noise:

• Recent illness or injury: Even a mild cold can elevate hs-CRP for one to two weeks. If you were sick before your blood draw, mention this to your provider. A single elevated reading during or shortly after illness is not reliable for cardiovascular risk assessment.
• Exercise timing: Hard training causes transient inflammatory responses (this is part of the adaptive process). hs-CRP can be elevated for 24–72 hours after strenuous exercise. Conversely, regular physical activity over weeks and months lowers baseline hs-CRP.
• Body composition: The relationship between body fat and hs-CRP is one of the strongest and most consistent findings in the inflammation literature. Even modest fat loss reduces hs-CRP levels.
• Sleep quality and duration: Both short sleep (under six hours) and sleep disorders are associated with elevated inflammatory markers.
• Diet patterns: Diets high in refined carbohydrates, trans fats, and processed foods are associated with higher CRP. Mediterranean-style diets are associated with lower levels.
• Smoking status: Smoking elevates hs-CRP. Cessation leads to measurable reductions, typically within weeks to months.
• Medications: Statins reduce hs-CRP independent of their cholesterol-lowering effects. NSAIDs and corticosteroids also suppress CRP. Your medication list is relevant to interpreting results.

COMMON QUESTIONS

“My hs-CRP is high — does that mean I have heart disease?”

Not necessarily. An elevated hs-CRP indicates increased systemic inflammation, which is one risk factor among many for cardiovascular disease. It does not diagnose the presence of plaque or predict an imminent event. It adds information — particularly for individuals at intermediate risk — but does not replace lipid panels, blood pressure, or other established risk factors. An elevated result is a signal that warrants further evaluation, not a diagnosis.

“Can exercise lower inflammation?”

Yes — the evidence is strong. Regular aerobic exercise significantly reduces hs-CRP levels across various populations. The anti-inflammatory effects work through multiple mechanisms: reduction of visceral fat, improved insulin sensitivity, and direct anti-inflammatory signals released from working muscles. The effect is dose-dependent — consistent moderate-to-vigorous activity over months produces larger reductions than short-term efforts.

“Should I retest if I was sick recently?”

Yes. Guidelines recommend that hs-CRP values above 10 mg/L be disregarded for cardiovascular risk assessment, as they likely reflect an acute process. Even values between 3–10 mg/L may be transiently elevated after illness. Best practice is to retest at least two weeks after full recovery, and to use the average of two measurements taken at least two weeks apart.

References

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143.
3. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. Journal of Clinical Investigation. 2003;111(12):1805-1812.
4. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease. Circulation. 2003;107(3):499-511.
5. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine. 2008;359(21):2195-2207.
6. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131-2135.
7. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis. Biological Psychiatry. 2016;80(1):40-52.
8. Fedewa MV, Hathaway ED, Ward-Ritacco CL. Effect of exercise training on C reactive protein: a systematic review and meta-analysis. British Journal of Sports Medicine. 2017;51(8):670-676.
9. Bray C, Bell LN, Liang H, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317-321.
10. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 2015;14:6.
11. Camaschella C. Iron-deficiency anemia. New England Journal of Medicine. 2015;372(19):1832-1843.
12. Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287-293.
13. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292(12):1440-1446.
14. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology. 2012;8(8):457-465.

UNDERSTAND YOUR NUMBERS

Inflammation markers add critical context to the rest of your blood work. Get a comprehensive panel and a provider who reads the full picture — not just isolated numbers.

Book Consultation